Larson Yi 4
4 · Turning Point Therapeutics, Inc. · Filed Feb 2, 2021
Insider Transaction Report
Form 4
Larson Yi
EVP & Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-01$54.03/sh+15,702$848,379→ 18,406 total - Sale
Common Stock
2021-02-01$122.94/sh−4,783$588,022→ 13,623 total - Sale
Common Stock
2021-02-01$124.60/sh−2,143$267,018→ 2,904 total - Exercise/Conversion
Common Stock
2021-02-02$54.03/sh+14,298$772,521→ 17,002 total - Sale
Common Stock
2021-02-02$128.41/sh−400$51,364→ 15,602 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-02−14,298→ 282,397 totalExercise: $54.03Exp: 2029-08-25→ Common Stock (14,298 underlying) - Sale
Common Stock
2021-02-02$129.80/sh−4,574$593,705→ 11,028 total - Sale
Common Stock
2021-02-02$131.73/sh−1,057$139,239→ 2,704 total - Sale
Common Stock
2021-02-01$123.70/sh−8,576$1,060,851→ 5,047 total - Sale
Common Stock
2021-02-01$126.07/sh−200$25,214→ 2,704 total - Sale
Common Stock
2021-02-02$127.58/sh−1,000$127,580→ 16,002 total - Sale
Common Stock
2021-02-02$130.58/sh−7,267$948,925→ 3,761 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-01−15,702→ 296,695 totalExercise: $54.03Exp: 2029-08-25→ Common Stock (15,702 underlying)
Footnotes (12)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 20, 2020.
- [F10]The weighted average sale price for the transaction reported was $130.58, and the range of prices were between $130.25 and $131.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F11]The weighted average sale price for the transaction reported was $131.73, and the range of prices were between $131.38 and $132.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F12]25% of the shares vested on August 26, 2020 with the remaining shares vesting in equal monthly installments over the following three years thereafter.
- [F2]The Reporting Person acquired 86 shares on June 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan (the "ESPP") and 396 shares on December 10, 2020 pursuant the ESPP.
- [F3]The weighted average sale price for the transaction reported was $122.94, and the range of prices were between $122.28 and $123.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The weighted average sale price for the transaction reported was $123.70, and the range of prices were between $123.29 and $124.29. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F5]The weighted average sale price for the transaction reported was $124.60, and the range of prices were between $124.34 and $125.04. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F6]The weighted average sale price for the transaction reported was $126.07, and the range of prices were between $125.58 and $126.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F7]The weighted average sale price for the transaction reported was $127.58, and the range of prices were between $127.00 and $127.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F8]The weighted average sale price for the transaction reported was $128.41, and the range of prices were between $128.12 and $128.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F9]The weighted average sale price for the transaction reported was $129.80, and the range of prices were between $129.215 and $130.18. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.